UKBizDB.co.uk

HEPATOTARGET THERAPEUTICS LTD.

PRI/LTD BY GUAR/NSC (Private, limited by guarantee, no share capital)

This company is commonly known as Hepatotarget Therapeutics Ltd.. The company was founded 5 years ago and was given the registration number 11782914. The firm's registered office is in BABRAHAM. You can find them at Definigen Limited Moneta B280, Babraham Research Campus, Babraham, Cambridgeshire. This company's SIC code is 72110 - Research and experimental development on biotechnology.

Company Information

Name:HEPATOTARGET THERAPEUTICS LTD.
Company Number:11782914
Company Type:PRI/LTD BY GUAR/NSC (Private, limited by guarantee, no share capital)
Status:Active
Incorporation Date:23 January 2019
End of financial year:30 June 2021
Jurisdiction:England - Wales
Industry Codes:
  • 72110 - Research and experimental development on biotechnology

Office Address & Contact

Registered Address:Definigen Limited Moneta B280, Babraham Research Campus, Babraham, Cambridgeshire, CB22 3AT
Country Origin:
Telephone:Unreported
Email Address:Unreported
Website:Unreported
Social:Unreported

Company Officers

Personal InformationRoleAppointedStatus
1, Harvey Lane, Hauxton, Cambridge, England, CB22 5FT

Director23 January 2019Active
Babraham Research Campus, Babraham, Cambridge, United Kingdom, CB22 3AT

Director23 January 2019Active
1, Harvey Lane, Hauxton, Cambridge, England, CB22 5FT

Director23 January 2019Active

People with Significant Control

Professor Ludovic Vallier
Notified on:23 January 2019
Status:Active
Date of birth:January 1972
Nationality:French
Country of residence:England
Address:1, Harvey Lane, Cambridge, England, CB22 5FT
Nature of control:
  • Ownership of shares 25 to 50 percent

Account Documents

Accounts

  • Last accounts submitted for period 31 March 2023 (1 year ago)
  • Accounts type was MICRO
  • Next accounts dated 31 March 2024
  • Due by 31 December 2024 (3 months remaining)

Confirmation Statement

  • Last submitted on 14 October 2023 (11 months ago)
  • Next confirmation dated 14 October 2024
  • Due by 28 October 2024 (0 months remaining)

Copyright © 2024. All rights reserved.